ARKG

ARK Genomic Revolution ETF · BATS

  • Category Equity
  • Expense Ratio 0.75%
  • Listing Date
  • Volume 2,041,500.0
  • Market Cap (AUM) $944.62M

Performance

+0.54%

1W

-9.14%

1M

-14.76%

3M

-17.39%

6M

-12.21%

YTD

-12.34%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Twist Bioscience Corp.TWST9.71%
  • CRISPR Therapeutics AGCRSP7.94%
  • Recursion Pharmaceuticals, Inc. Class ARXRX6.26%
  • CareDx, Inc.CDNA5.99%
  • Intellia Therapeutics, Inc.NTLA4.65%
  • Ionis Pharmaceuticals, Inc.IONS4.18%
  • Arcturus Therapeutics Holdings, Inc.ARCT3.78%
  • Nurix Therapeutics, Inc.NRIX3.72%
  • Beam Therapeutics, Inc.BEAM3.62%
  • Moderna, Inc.MRNA3.57%

Technical Analysis of ARKG 2025-04-17

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 16 indicating strong downward momentum, an Oscillators Score of 45 suggesting a neutral stance, and a Technical Score of 30 reinforcing the bearish outlook. This combination implies that the stock is currently facing significant selling pressure, with limite...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.